SODIUM IODIDE I 131 CAPSULE, USP DIAGNOSTIC ORAL , Rx only, Manufactured by Jubilant DraxImage, Inc., Kirkland, QC, Canada, NDC 65174-461-05
Published April 13, 2016 · Recall initiated: March 11, 2016
Summary
FDA records drug Class III recall D-0812-2016, published April 13, 2016 and initiated March 11, 2016. Recalling firm: Jubilant Draximage Inc; Status: Terminated; Reported quantity: 90 vials (450 capsules); Lot: Lot Number 1670123; Exp 04/16. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error on Declared Strength
What to do
Voluntary: Firm initiated · E-Mail
Get an email if SODIUM IODIDE I 131 DIAGNOSTIC has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SODIUM IODIDE I 131 DIAGNOSTIC
- Manufacturer
- Jubilant Draximage Inc
- Distributor
- Nationwide
- Lot
- Lot Number 1670123; Exp 04/16
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Canada
Related recalls
- FDAMinocycline Hydrochloride Capsules USP, 100 mg*, 30 Capsules (3 x 10) Unit Dose blisters (NDC 50268-569-11,April 13, 2016
- FDADextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine SulfateApril 13, 2016
- FDARanitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL (75 mg/5 mL), 16 fl oz Bottle, Rx only, Mfd For:April 13, 2016
- FDADextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine SulfateApril 13, 2016
- FDAFormula 0 (PGE 20 mcg/mL) Injection, 5 mL vials, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave.,April 13, 2016
- FDADextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine SulfateApril 13, 2016
Questions about this recall
Was SODIUM IODIDE I 131 CAPSULE, USP DIAGNOSTIC ORAL , Rx only, Manufactured by Jubilant DraxImage, Inc., Kirkland, QC, Canada, NDC 65174-461-05 recalled?
Yes. FDA published recall D-0812-2016 on April 13, 2016. Reported hazard: Labeling: Label Error on Declared Strength
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SODIUM IODIDE I 131 DIAGNOSTIC.